Riskpilot← Back to searchSign inGet full accessSweden Re Well AB
ABActiveOrg 5591750855Kölnagatan 4General medical practice activities · NACE 8621Est. 20184 employees
Revenue 2024
SEK 14,9M
+6% vs 2023
EBITDA margin
17.6%
+808% vs 2023
Equity ratio
3.9%
Financial strength
Net profit 2024
SEK 724
+100% vs 2023
| Revenue | SEK 14,9M | +6% |
| EBITDA | SEK 2,6M | +808% |
| Net profit | SEK 724 | +100% |
| Total assets | SEK 1,4M | -52% |
| Equity | SEK 55K | +2% |
| Employees | 4 | — |
Legal name
Sweden Re Well AB
Org number
5591750855
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
12 oktober 2018
Share capital
SEK 50 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva medicinsk analys och hälsovård, forskning, partihandel med läkemedel och medicinska varor, medicinsk konsultverksamhet samt därmed förenlig verksamhet.
Address
Kölnagatan 4
Email
par.svensson@rewell.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 764 | 8 321 | 10 455 | 14 023 | 14 877 |
| Staff expenses | — | — | −5 107 | — | −2 679 |
| EBITDA | −6 484 | −7 182 | −5 389 | −370 | 2 620 |
| Depreciation & amort. | −0 | −0 | — | −0 | — |
| EBIT | −6 484 | −7 182 | −5 389 | −370 | 2 620 |
| Net financials | −15 | −6 | −18 | — | −1 |
| Profit before tax | −6 499 | −7 188 | −5 408 | −370 | 1 |
| Tax | −0 | −0 | — | −0 | — |
| Net profit | −6 499 | −7 188 | −5 408 | −370 | 1 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 067 | 2 894 | 2 539 | 2 950 | 1 410 |
| Equity | 551 | 54 | 54 | 54 | 55 |
| Long-term debt | 0 | 0 | — | 0 | — |
| Short-term debt | 1 516 | 2 840 | 2 485 | 2 895 | 1 355 |
| Total debt | 1 516 | 2 840 | 2 485 | 2 895 | 1 355 |
EBITDA margin
17.6%
This company
15.8%
Market median
+11% vs market
20202024
Equity ratio
3.9%
This company
38.2%
Market median
-90% vs market
20202024
Return on equity
1.3%
This company
18.4%
Market median
-93% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
10.55×
This company
1.12×
Market median
+842% vs market
20202024
Debt / equity
24.62×
This company
0.62×
Market median
-3871% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PK Chief Executive Officer | Chief Executive Officer | 2024 |
HP | Audit | 2021 |
| Former (2) | ||
PA Audit | Audit | 2022 – 2023 |
KJ Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
| Former (3) | ||
| Deputy Board Member | 2021 – 2022 | |
| Chairman | 2021 – 2022 | |
| Deputy Board Member | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Rewell Medical AB
Sweden Re Well AB Board members of Sweden Re Well AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Anders Fridolin | Audit | 0 companies |
| Pär Karl Axel Svensson | Chief Executive Officer | 0 companies |
| Karl Jonas Thörnholm | Chief Executive Officer | 0 companies |
| Hans Peter Gustafsson | Audit | 0 companies |
| Jasinta Cecilia Rajan | Deputy Board Member | 0 companies |
| Jan Krister Nilsson | Chairman | 0 companies |
| Filip Weintraub | Deputy Board Member | 0 companies |
| Per Fredrik Bexelius | Deputy Board Member | 0 companies |